Auszug
Eine sachgerechte ovarielle Stimulation verfolgt verschiedene Ziele:
-
Einleitung einer Follikelreifung,
-
Gewinnung von reifen Eizellen,
-
Adäquate Vorbereitung des Endometriums,
-
Erzielung einer ausreichenden Corpus-luteum-Funktion,
-
Vermeidung von Mehrlingsgraviditäten,
-
Vermeidung eines OHSS (»ovarian hyper-stimulation-snydrome«).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Bulletti C, De Ziegler D, Flamigni C et al. (1997) Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod 12:1073–1079
Cicinelli E, De Ziegler D (1999) Transvaginal progesterone: evidence for a new functional ‘portal system’ flowing from the vagina to the uterus. Hum Reprod Update 5:365–372
Cicinelli E, Cignarelli M, Sabatelli S et al. (1998) Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women. Fertil Steril 69:471–473
De Ziegler D (1995) Hormonal control of endometrial receptivity. Hum Reprod 10:4–7
Golan A, Ron-El R, Herman A et al. (1988) Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization. Fertil Steril 50:912–916
Fanchin R, Righini C, Olivennes F et al. (1998) Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod 13:1968–1974
Fanchin R, Ayoubi JM, Olivennes F et al. (2000) Hormonal influence on the uterine contractility during ovarian stimulation. Hum Reprod 15(Suppl 1):90–100
Fanchin R, Ayoubi JM, Righini C et al. (2001) Uterine contractility decreases at the time of blastocyst transfers. Hum Reprod 16:1115–1119
Fauser BC, de Jong D, Olivennes F et al. (2002) Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87:709–715
Kaiser UB (2003) The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 349:729–732.
Kolibianakis EM, Zikopoulos KA, Fatemi HM et al. (2004) Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. Reprod Biomed Online 8:115–118
Kovacs P, Matyas S, Boda K et al. (2003) The effect of endometrial thickness on IVF/ICSI outcome. Hum Reprod 18:2337–2341
Ludwig M, Jelkmann W, Bauer O et al. (1999) Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 14:2437–2441
Ludwig M, Felberbaum RE, Diedrich K (1999) Interactions of GnRH analogues and gonadotrophins. In: Adashi EY, Baird DT, Crosignani PG (Hrsg) Gonadotrophins and Fertility. 1 Aufl Rom, Christengraf 125–143
Ludwig M, Felberbaum RE, Diedrich K et al. (2002) Ovarian stimulation: from basic science to clinical application. Reprod Biomed Online 5(Suppl 1) 73–66
Miles RA, Paulson RJ, Lobo RA et al. (1994) Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 62:485–490
Porter RN, Smith W, Craft IL et al. (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2:1284–1285
Rabau E, David A, Serr DM et al. (1967) Human menopausal gonadotropins for anovulation and sterility. Am J Obstet Gynecol 98:92–98
Recombinant LH study group (2001) Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 86:2607–2618
Smits G, Olatunbosun O, Delbaere A et al. (2003) Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med. 2003;349:760–766
Stanger JD, Yovich JL (1985) Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 92:385–393
Vasseur C, Rodien P, Beau I et al. (2003) A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 349:753–759
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
(2007). Grundlagen der ovariellen Stimulation. In: Kinderwunschsprechstunde. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70979-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-540-70979-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70978-7
Online ISBN: 978-3-540-70979-4
eBook Packages: Medicine (German Language)